Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Papillomavirus Infections | 5 | 2019 | 861 | 1.12 | Why? |
| Papillomaviridae | 3 | 2019 | 404 | 0.82 | Why? |
| Circulating Tumor DNA | 1 | 2019 | 46 | 0.77 | Why? |
| Oropharyngeal Neoplasms | 2 | 2019 | 138 | 0.72 | Why? |
| Incidental Findings | 1 | 2020 | 487 | 0.61 | Why? |
| Equipment and Supplies | 1 | 2020 | 440 | 0.58 | Why? |
| Head and Neck Neoplasms | 2 | 2019 | 1568 | 0.39 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.27 | Why? |
| Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.26 | Why? |
| Human papillomavirus 16 | 2 | 2019 | 95 | 0.23 | Why? |
| Acetylcholine | 1 | 2021 | 53 | 0.22 | Why? |
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2021 | 92 | 0.21 | Why? |
| Glomerulonephritis, Membranous | 1 | 2020 | 71 | 0.20 | Why? |
| APOBEC-3G Deaminase | 1 | 2018 | 33 | 0.19 | Why? |
| Lymphoma, B-Cell | 1 | 2021 | 166 | 0.19 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.18 | Why? |
| Anus Diseases | 1 | 2018 | 55 | 0.18 | Why? |
| Alphapapillomavirus | 1 | 2018 | 107 | 0.17 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.16 | Why? |
| Paris | 1 | 2020 | 1287 | 0.16 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.15 | Why? |
| HIV Protease Inhibitors | 1 | 2019 | 434 | 0.15 | Why? |
| Interferon-beta | 1 | 2020 | 979 | 0.13 | Why? |
| Biopsy | 2 | 2020 | 2811 | 0.13 | Why? |
| Convalescence | 2 | 2021 | 2829 | 0.13 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Genotype | 3 | 2019 | 4697 | 0.12 | Why? |
| Drug Resistance, Viral | 1 | 2019 | 1083 | 0.12 | Why? |
| Hot Temperature | 1 | 2020 | 1299 | 0.12 | Why? |
| Interferon-alpha | 1 | 2020 | 1442 | 0.12 | Why? |
| Virus Inactivation | 1 | 2020 | 1139 | 0.11 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2019 | 1439 | 0.11 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.11 | Why? |
| Central African Republic | 2 | 2020 | 37 | 0.10 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.10 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.10 | Why? |
| Serologic Tests | 2 | 2020 | 4359 | 0.10 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.10 | Why? |
| Homosexuality, Male | 1 | 2018 | 1158 | 0.09 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.09 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.09 | Why? |
| Viral Load | 5 | 2021 | 15850 | 0.09 | Why? |
| Nucleocapsid Proteins | 1 | 2021 | 3120 | 0.09 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.09 | Why? |
| HIV-1 | 2 | 2021 | 3365 | 0.09 | Why? |
| France | 5 | 2021 | 12074 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2019 | 1956 | 0.08 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.08 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.08 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.07 | Why? |
| False Positive Reactions | 2 | 2021 | 1338 | 0.07 | Why? |
| Humans | 23 | 2021 | 930598 | 0.07 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.07 | Why? |
| Germany | 1 | 2020 | 9196 | 0.07 | Why? |
| HIV Infections | 2 | 2021 | 11620 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.07 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.06 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.06 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.06 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 11367 | 0.05 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.05 | Why? |
| Apolipoproteins B | 1 | 2018 | 47 | 0.05 | Why? |
| Retreatment | 1 | 2019 | 186 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 45 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.04 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2019 | 309 | 0.04 | Why? |
| DNA, Viral | 2 | 2018 | 2521 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| Cervix Uteri | 1 | 2018 | 146 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Allografts | 1 | 2020 | 761 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.04 | Why? |
| Female | 10 | 2021 | 380317 | 0.04 | Why? |
| Blood Component Transfusion | 1 | 2020 | 740 | 0.04 | Why? |
| Anal Canal | 1 | 2018 | 367 | 0.04 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.04 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.03 | Why? |
| Hemostasis | 1 | 2020 | 811 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 952 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Alleles | 1 | 2019 | 1557 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Treatment Failure | 1 | 2019 | 2106 | 0.03 | Why? |
| NF-kappa B | 1 | 2020 | 1301 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2020 | 1387 | 0.03 | Why? |
| Africa | 1 | 2020 | 2986 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Phylogeny | 2 | 2019 | 13341 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2020 | 2483 | 0.03 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.02 | Why? |
| Endothelial Cells | 1 | 2020 | 2048 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 9335 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.02 | Why? |
| Sexual Behavior | 1 | 2018 | 1322 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2020 | 3788 | 0.02 | Why? |
| Mutation | 2 | 2019 | 12376 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.02 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.02 | Why? |
| Hematologic Neoplasms | 1 | 2020 | 2105 | 0.02 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
Veyer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(146)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(202)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_